A detailed history of Simplex Trading, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Simplex Trading, LLC holds 33,841 shares of PDSB stock, worth $114,044. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,841
Previous 21,653 56.29%
Holding current value
$114,044
Previous $85,000 16.47%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$2.55 - $4.02 $31,079 - $48,995
12,188 Added 56.29%
33,841 $99,000
Q1 2024

Apr 25, 2024

SELL
$3.85 - $6.59 $13,205 - $22,603
-3,430 Reduced 13.67%
21,653 $85,000
Q4 2023

Feb 02, 2024

SELL
$3.95 - $6.58 $65,001 - $108,280
-16,456 Reduced 39.62%
25,083 $124,000
Q3 2023

Nov 01, 2023

SELL
$4.8 - $6.4 $8,323 - $11,097
-1,734 Reduced 4.01%
41,539 $209,000
Q2 2023

Aug 04, 2023

BUY
$5.03 - $9.9 $155,899 - $306,840
30,994 Added 252.41%
43,273 $217,000
Q1 2023

Apr 27, 2023

BUY
$5.68 - $11.99 $3,152 - $6,654
555 Added 4.73%
12,279 $75,000
Q4 2022

Feb 02, 2023

BUY
$3.28 - $13.2 $38,454 - $154,756
11,724 New
11,724 $154,000
Q2 2022

Aug 03, 2022

BUY
$3.05 - $6.68 $40,949 - $89,685
13,426 New
13,426 $49,000
Q1 2022

May 02, 2022

SELL
$4.78 - $8.43 $68,879 - $121,476
-14,410 Closed
0 $0
Q4 2021

Feb 23, 2022

BUY
$7.76 - $14.35 $63,135 - $116,751
8,136 Added 129.68%
14,410 $116,000
Q3 2021

Oct 28, 2021

BUY
$9.33 - $17.08 $933 - $1,707
100 Added 1.62%
6,274 $77,000
Q2 2021

Aug 12, 2021

BUY
$4.35 - $12.86 $26,856 - $79,397
6,174 New
6,174 $77,000

Others Institutions Holding PDSB

About PDS Biotechnology Corp


  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $95.9M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.